AETHLON MEDICAL, INC. Other Noncash Income (Expense)
AETHLON MEDICAL, INC. (AEMD) reported Other Noncash Income (Expense) of -$4.05 million for the 12-month period ending 2025-03-31, per its 10-K filed 2025-06-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2025-06-26
- AETHLON MEDICAL, INC. other noncash income (expense) for fiscal 2025 was -$4.05M, a 1044.63% decline from fiscal 2024.
- AETHLON MEDICAL, INC. other noncash income (expense) for fiscal 2024 was $428.39K.
- AETHLON MEDICAL, INC. other noncash income (expense) for fiscal 2023 was -$131.15K.
- AETHLON MEDICAL, INC. other noncash income (expense) for fiscal 2022 was $0.00.
| Period end | Other Noncash Income (Expense) 12 month |
|---|---|
| 2025-03-31 | -$4.05M 10-K · filed 2025-06-26 |
| 2024-03-31 | $428.39K 10-K · filed 2025-06-26 |
| 2023-03-31 | -$131.15K 10-K · filed 2024-06-27 |
| 2022-03-31 | $0.00 10-K · filed 2023-06-28 |
| 2013-03-31 | $11.85K 10-K · filed 2013-07-15 |
| 2012-03-31 | $156.10K 10-K · filed 2013-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |